{
  "id": "340d4a15f7bbe45f",
  "title": "Cardiopat\u00edas cong\u00e9nitas : cuando la filantrop\u00eda cubre vac\u00edos estructurales",
  "description": "20260218T091500Z",
  "content": "",
  "source": "elfinanciero.com.mx",
  "source_url": "https://www.elfinanciero.com.mx/opinion/arturo-castillo/2026/02/18/cardiopatias-congenitas-cuando-la-filantropia-cubre-vacios-estructurales/",
  "published_at": "20260218T091500Z",
  "fetched_at": "2026-02-19T00:30:34.211663+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Mexico",
  "raw_data": {
    "url": "https://www.elfinanciero.com.mx/opinion/arturo-castillo/2026/02/18/cardiopatias-congenitas-cuando-la-filantropia-cubre-vacios-estructurales/",
    "url_mobile": "",
    "title": "Cardiopat\u00edas cong\u00e9nitas : cuando la filantrop\u00eda cubre vac\u00edos estructurales",
    "seendate": "20260218T091500Z",
    "socialimage": "https://www.elfinanciero.com.mx/resizer/v2/MJ5PGVQYQFDTNK6NOFJSEYV6PE.jpg?smart=true&auth=2efcdc80c77783341376b147c087f37e7ce4e3df1c9473dddc2b31ae5a3060ae",
    "domain": "elfinanciero.com.mx",
    "language": "Spanish",
    "sourcecountry": "Mexico"
  }
}